MedPath

Aspen Pharmacare Australia Pty Ltd.

🇦🇺Australia
Ownership
Subsidiary
Employees
-
Market Cap
-
Website
http://www.aspenpharma.com.au

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

533

TGA:513
NMPA:18
SFDA:2

Drug Approvals

Ropivacaine Hydrochloride Injection

Product Name
耐乐品
Approval Number
国药准字HJ20140766
Approval Date
Dec 31, 2024
NMPA

Ropivacaine Hydrochloride Injection

Product Name
耐乐品
Approval Number
国药准字HJ20140763
Approval Date
Dec 31, 2024
NMPA

Ropivacaine Hydrochloride Injection

Product Name
耐乐品
Approval Number
国药准字HJ20140764
Approval Date
Dec 31, 2024
NMPA

Lidocaine and Prilocaine Cream

Product Name
恩纳
Approval Number
国药准字HJ20100154
Approval Date
Sep 9, 2024
NMPA

Chlorambucil Tablets

Product Name
留可然
Approval Number
国药准字HJ20170291
Approval Date
Oct 10, 2023
NMPA

Melphalan Tablets

Product Name
爱克兰
Approval Number
国药准字HJ20171317
Approval Date
May 10, 2023
NMPA

Cisatracurium Besylate Injection

Product Name
赛机宁
Approval Number
国药准字HJ20181159
Approval Date
Jun 11, 2021
NMPA

Cisatracurium Besylate Injection

Product Name
赛机宁
Approval Number
国药准字HJ20181157
Approval Date
Jun 11, 2021
NMPA

Cisatracurium Besylate Injection

Product Name
赛机宁
Approval Number
国药准字HJ20181158
Approval Date
Jun 11, 2021
NMPA

Azathioprine Tablets

Product Name
依木兰
Approval Number
国药准字HJ20170288
Approval Date
Sep 30, 2020
NMPA
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.